Abbott Laboratories Releasing Previously Held Formulas at FDA's Request
29 Avril 2022 - 11:25PM
Dow Jones News
By Denny Jacob
Abbott Laboratories said Friday that it is releasing limited
quantities of metabolic nutrition formulas that were previously on
hold at the request of the Food and Drug Administration.
The company said the formulas were previously on hold following
its recall of some powder infant formulas from its Sturgis, Mich.,
facility.
The company said the products being released weren't included in
the recall. It added that the products have been tested and comply
with all product release requirements before distribution.
Abbott said it has implemented corrective actions and is working
with the FDA to address the situation before resuming operations at
its facility. It said it will take at least six to eight weeks for
products to be available for distribution once it can resume
production.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
April 29, 2022 17:10 ET (21:10 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Abbott Laboratories (NYSE:ABT)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024
Abbott Laboratories (NYSE:ABT)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024